Skip to main content
. Author manuscript; available in PMC: 2013 Mar 22.
Published in final edited form as: FEMS Immunol Med Microbiol. 2011 Apr 15;62(2):164–172. doi: 10.1111/j.1574-695X.2011.00800.x

Table 3.

Serum anti-toxin IgG levels in cutaneous anthrax patients

Patient Days after Onset of Symptoms Anti-PA IgG Anti-LF IgG Anti-EF IgG
Naive --- 11.6(5.4) 5.6(4.1) 6.5(6.0)
1 5 <NB <NB <NB
12 <NB 147.4(19.0) <NB
2 4 <NB <NB <NB
13 21.6 (6.4) 117.3(26.8) <NB
3 4 <NB 13.6(3.2) <NB
9 <NB 16.0(3.7) <NB
5 6 <NB 15.7(2.1) 14.7(1.5)
13 <NB 141.0(19.3) 27.1(2.7)
6 5 <NB <NB <NB
20 26.1(2.2) 430.8(91.0) 24.3(1.6)
7 5 <NB <NB <NB
15 19.3(4.8) 71.9(18.1) <NB
8 4 <NB <NB <NB
9 <NB 35.6(13.6) 60.5(7.9)
13 <NB 68.7(18.5) 31.9(8.2)
9 15 <NB 28.9(9.6) <NB
10a 7 <NB 31.0(8.2) <NB
16 14 <NB 214.3(24.4) <NB
21 <NB 817.6(202.8) 26.2(7.6)
17 7 <NB <NB <NB
15 <NB 60.2(10.9) <NB

Data are in micrograms/milliliter and represent the mean titer (+/- standard deviation) as determined by ELISA

a

Patient developed septicemia from cutaneous lesion

<NB, less than the naïve baseline (titer indistinguishable from naïve controls)